The drug discovery services market size is poised to grow by $ 33.2 billion by 2030 from $ 14.11 Billion in 2022, exhibiting a CAGR of 11.3% during the forecast period 2022 to 2030.
The main objective of this report is to define, describe, and forecast the global market by types, application, manufacturers, and regions. The report provides detailed information about the major factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the market. The report aims to strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market. The report also attempts to forecast the market size of the 5 main regions: North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It strategically profiles the key market players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as joint ventures, mergers and acquisitions, new developments, and Research and Development (R&D) activities, in market.
Get a Sample: https://www.precedenceresearch.com/sample/1532
COVID-19 Impact
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the electric vehicle fuel cell market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Major companies operating in this are
- Abbott Laboratories Inc.
- Advinus Therapeutics
- Agilent Technologies Ubiquigent
- Albany Molecular Research Inc.
- AstraZeneca PLC
- Aurigene
- Bayer AG
- Charles River Laboratories International
- ChemBridge Corporation
- Covance
Market Segmentation
By Process
- Target Selection
- Target Validation
- Hit to Lead Identification
- Lead Optimization
- Candidate Validation
By Drug Type
- Small Molecules
- Biologics
By Type
- DMPK
- Biology Services
- Medicinal Chemistry
By Therapeutic Area
- Oncology
- Cardiovascular Diseases
- Diabetes
- Neurology
- Respiratory Diseases
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Major highlights of Report:
- Figures related to sales volume, market remuneration, and segmental shares
- Featuring market dynamics
- Growth prospects and expansion graph
- PROCON study of direct & indirect sales channels
- Profiles of prominent traders, dealer, and distributors in the industry
Geographical landscape: North America, Europe, Asia-Pacific, South America, Middle East and Africa
- Industry forecasts based on region and at country level
- Data about sales volume recorded, industry share held, and profit margins amassed
- Overall remuneration and estimated growth rate for each regional market
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Drug Discovery Services Market
5.1. COVID-19 Landscape: Drug Discovery Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Drug Discovery Services Market, By Process
8.1. Drug Discovery Services Market, by Process Type, 2021-2030
8.1.1. Target Selection
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Target Validation
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Hit to Lead Identification
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Lead Optimization
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Candidate Validation
8.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Drug Discovery Services Market, By Drug Type
9.1. Drug Discovery Services Market, by Drug Type, 2021-2030
9.1.1. Small Molecules
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Biologics
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Drug Discovery Services Market, By Type
10.1. Drug Discovery Services Market, by Type, 2021-2030
10.1.1. DMPK
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Biology Services
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Medicinal Chemistry
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Drug Discovery Services Market, By Therapeutic Area
11.1. Drug Discovery Services Market, by Therapeutic Area Type, 2021-2030
11.1.1. Oncology
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Cardiovascular Diseases
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Diabetes
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Neurology
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Respiratory Diseases
11.1.5.1. Market Revenue and Forecast (2019-2030)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Drug Discovery Services Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Process (2019-2030)
12.1.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.1.3. Market Revenue and Forecast, by Type (2019-2030)
12.1.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Process (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Process (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Process (2019-2030)
12.2.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.3. Market Revenue and Forecast, by Type (2019-2030)
12.2.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Process (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Process (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Process (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Process (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Process (2019-2030)
12.3.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.3. Market Revenue and Forecast, by Type (2019-2030)
12.3.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Process (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Process (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Process (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Process (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Process (2019-2030)
12.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.3. Market Revenue and Forecast, by Type (2019-2030)
12.4.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Process (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Process (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Process (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Process (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Process (2019-2030)
12.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.5.3. Market Revenue and Forecast, by Type (2019-2030)
12.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Process (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Process (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by Therapeutic Area Type (2019-2030)
Chapter 13. Company Profiles
13.1. Abbott Laboratories Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Advinus Therapeutics
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Agilent Technologies Ubiquigent
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Albany Molecular Research Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. AstraZeneca PLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Aurigene
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bayer AG
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Charles River Laboratories International
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. ChemBridge Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Covance
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments